BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20473206)

  • 1. An integrated evidence rating to frame comparative effectiveness assessments for decision makers.
    Ollendorf DA; Pearson SD
    Med Care; 2010 Jun; 48(6 Suppl):S145-52. PubMed ID: 20473206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maximizing the clinical utility of comparative effectiveness research.
    Umscheid CA
    Clin Pharmacol Ther; 2010 Dec; 88(6):876-9. PubMed ID: 20962776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining comparative effectiveness research: the importance of getting it right.
    Sox HC
    Med Care; 2010 Jun; 48(6 Suppl):S7-8. PubMed ID: 20473202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How the Patient-Centered Outcomes Research Institute can best influence real-world health care decision making.
    Garber AM
    Health Aff (Millwood); 2011 Dec; 30(12):2243-51. PubMed ID: 22147851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methodological challenges of comparative effectiveness research in pain: implications for investigators, clinicians, and policy makers.
    Bellows BK; Biskupiak J
    J Pain Palliat Care Pharmacother; 2011; 25(3):267-74. PubMed ID: 21882980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing applicability when comparing medical interventions: AHRQ and the Effective Health Care Program.
    Atkins D; Chang SM; Gartlehner G; Buckley DI; Whitlock EP; Berliner E; Matchar D
    J Clin Epidemiol; 2011 Nov; 64(11):1198-207. PubMed ID: 21463926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of comparative effectiveness research in drug coverage and pricing decisions: a six-country comparison.
    Sorenson C
    Issue Brief (Commonw Fund); 2010 Jul; 91():1-14. PubMed ID: 20614655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based medicine: can it be applied to stimulation of erythropoiesis for patients with malignancy?
    Rizzo JD
    Best Pract Res Clin Haematol; 2005; 18(3):439-48. PubMed ID: 15792918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why observational studies should be among the tools used in comparative effectiveness research.
    Dreyer NA; Tunis SR; Berger M; Ollendorf D; Mattox P; Gliklich R
    Health Aff (Millwood); 2010 Oct; 29(10):1818-25. PubMed ID: 20921481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the value for money of changing clinical practice change: a stochastic application in diabetes care.
    Hoomans T; Abrams KR; Ament AJ; Evers SM; Severens JL
    Med Care; 2009 Oct; 47(10):1053-61. PubMed ID: 19648827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of costs in comparative effectiveness research.
    Garber AM; Sox HC
    Health Aff (Millwood); 2010 Oct; 29(10):1805-11. PubMed ID: 20921479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The policies and politics of creating a comparative clinical effectiveness research center.
    Wilensky GR
    Health Aff (Millwood); 2009; 28(4):w719-29. PubMed ID: 19556248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Veterans Affairs experience: comparative effectiveness research in a large health system.
    Atkins D; Kupersmith J; Eisen S
    Health Aff (Millwood); 2010 Oct; 29(10):1906-12. PubMed ID: 20921493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Medicare could use comparative effectiveness research in deciding on new coverage and reimbursement.
    Pearson SD; Bach PB
    Health Aff (Millwood); 2010 Oct; 29(10):1796-804. PubMed ID: 20921478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting cost-effectiveness analysis for preventive interventions: a guide for decision makers.
    Teutsch SM; Murray JF
    Am J Manag Care; 1999 Mar; 5(3):301-5. PubMed ID: 10351026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translating comparative effectiveness into practice: the case of diabetes medications.
    Shah ND; Mullan RJ; Breslin M; Yawn BP; Ting HH; Montori VM
    Med Care; 2010 Jun; 48(6 Suppl):S153-8. PubMed ID: 20473211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.